Thu, March 31, 2011
[ Thu, Mar 31st 2011 ]: Market Wire
MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. sent at 10th Annual Needham Healthcare Conference
[ Thu, Mar 31st 2011 ]: Market Wire
A CIGNA bel©pett a globlis egy©ni eg©szs©gbiz .. zette a CIGNA Globlis Eg©szs©gbiztostsi Opcikat
[ Thu, Mar 31st 2011 ]: Market Wire
PROTOX REPORTS 2010 FINANCIAL RESULTS AND ACHIEVEMENTS
[ Thu, Mar 31st 2011 ]: Market Wire
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
[ Thu, Mar 31st 2011 ]: Market Wire
RXi Pharmaceuticals Aggressively Moves into Late- .. pment with the Agreement to Acquire Apthera, Inc.
[ Thu, Mar 31st 2011 ]: Market Wire
AVEO Pharmaceuticals, Inc. to Present at the Leerink Swann Cancer Roundtable Conference
[ Thu, Mar 31st 2011 ]: Market Wire
Interim Phase 2 Data Showed Rapid Viral Response .. Telaprevir, Pegylated-Interferon and Ribavirin A
[ Thu, Mar 31st 2011 ]: Market Wire
SuperGen PIM Kinase Presentations at AACR
[ Thu, Mar 31st 2011 ]: Market Wire
SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011
[ Thu, Mar 31st 2011 ]: Market Wire
A.P. Pharma Announces Transfer to OTCQB
[ Thu, Mar 31st 2011 ]: Market Wire
Inhibitex Reports Positive Safety and Antiviral D .. hase 1b Study of HCV Nucleotide Inhibitor INX-189
[ Thu, Mar 31st 2011 ]: Market Wire
Inhibitex Announces Data Presentation at the 46th .. ean Association for the Study of the Liver (EASL)
[ Thu, Mar 31st 2011 ]: Market Wire
The New England Journal of Medicine Publishes Stu .. ational Medicine VICTRELISa" (boceprevir) in Comb
Wed, March 30, 2011
[ Wed, Mar 30th 2011 ]: Market Wire
CIGNA betritt Privatkundensegment mit neuer Krankenversicherung CIGNA Global Health Options
[ Wed, Mar 30th 2011 ]: Market Wire
CIGNA entra nel mercato sanitario globale per le persone lanciando CIGNA Global Health Options
[ Wed, Mar 30th 2011 ]: Market Wire
Antrim Energy Inc. Announces the Filing of Its National Instrument 51-101 Reports
[ Wed, Mar 30th 2011 ]: Market Wire
Baby, It's Cold Outside, But Pharmaceutical Industry Is Hot, an Industrial Info News Alert
[ Wed, Mar 30th 2011 ]: Market Wire
Bernstein Liebhard LLP Announces Investigation of Offer for Cephalon, Inc.
[ Wed, Mar 30th 2011 ]: Market Wire
Yale and Gilead Sciences Announce Cancer Research Collaboration
[ Wed, Mar 30th 2011 ]: Market Wire
Curis Announces Presentations at 102nd American A .. sociation for Cancer Research Annual Meeting 2011
[ Wed, Mar 30th 2011 ]: Market Wire
Medivation and Astellas Announce Initiation of Ph .. ng MDV3100 With Bicalutamide in Advanced Prostate
[ Wed, Mar 30th 2011 ]: Market Wire
BioSante Pharmaceuticals Completes Enrollment in Both Pivotal LibiGel® Phase III Efficacy Trials
[ Wed, Mar 30th 2011 ]: Market Wire
Derma Sciences Reports Fourth Quarter Results; Sa .. oducts up 59% over Prior Year; Total Net Sales Ne
[ Wed, Mar 30th 2011 ]: Market Wire
Dr. Reddya?s Announces Completion of the Acquisit .. cillin Facility and Products from GlaxoSmithKline
[ Wed, Mar 30th 2011 ]: Market Wire
Columbia Laboratories' Provides Update on PREGNANT Study Publication
Tue, March 29, 2011
[ Tue, Mar 29th 2011 ]: Market Wire
Somaxon Pharmaceuticals Announces Issuance of Pat .. ting to Pharmacokinetics (Food Effect) of Silenor
[ Tue, Mar 29th 2011 ]: Market Wire
Merc Completes Final Tranche of Private Placement
[ Tue, Mar 29th 2011 ]: Market Wire
ACADIA Pharmaceuticals to Present at the Tenth An .. al Needham Healthcare Conference on April 5, 2011
[ Tue, Mar 29th 2011 ]: Market Wire
Biomagneticsa? Updates on Commercialization of the IOBS Unit
[ Tue, Mar 29th 2011 ]: Market Wire
NuPathe to Present at the 10th Annual Needham Healthcare Conference
[ Tue, Mar 29th 2011 ]: Market Wire
(NYSE Amex: DXR) Daxor Corporation Announces Year End 2010 Earnings
[ Tue, Mar 29th 2011 ]: Market Wire
Curis to Present at the 10th Annual Needham Healthcare Conference
[ Tue, Mar 29th 2011 ]: Market Wire
Derma Sciences Advanced Wound Care Products Featu .. tions at the Diabetic Foot Global Conference 2011
[ Tue, Mar 29th 2011 ]: Market Wire
Phase 3 Study of VX-770 in Children Ages 6 to 11 .. c Fibrosis Showed Profound Improvements in Lung F
[ Tue, Mar 29th 2011 ]: Market Wire
Advisory Contract between Medwell Capital and Spectral Diagnostics Increases
[ Tue, Mar 29th 2011 ]: Market Wire
Medical Facilities Corporation Proposes Conversion to Traditional Common Share Structure
[ Tue, Mar 29th 2011 ]: Market Wire
ZIOPHARM to Present at Upcoming Investor Conferences
Mon, March 28, 2011
[ Mon, Mar 28th 2011 ]: Market Wire
Clinical and Economic Data From The PARTNER Trial to Be Presented at ACC 2011
[ Mon, Mar 28th 2011 ]: Market Wire
Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11
[ Mon, Mar 28th 2011 ]: Market Wire
Cambridge Hearta?s MTWA Test Featured as Case of .. Week in Diagnostic and Interventional Cardiology
[ Mon, Mar 28th 2011 ]: Market Wire
EnteroMedics Receives CE Mark Certification for t .. g Australian Regulatory Application to Move Forwa
[ Mon, Mar 28th 2011 ]: Market Wire
PacificHealth Laboratories Launches ACCEL RECOVER(R)
[ Mon, Mar 28th 2011 ]: Market Wire
CytRx Announces the Presentation of Bafetinib Stu .. Academy for Cancer Research (AACR) Annual Meeting
[ Mon, Mar 28th 2011 ]: Market Wire
AVI BioPharma Names Peter S. Linsley, Ph.D., Chief Scientific Officer
[ Mon, Mar 28th 2011 ]: Market Wire
Implant Sciences Announces $380,000 in New Contra .. Quantum Sniffer Explosives Trace Detection Device
[ Mon, Mar 28th 2011 ]: Market Wire
Treating Skeletal Muscle Injuries With Pluristem's PLacental eXpanded (PLX) Cells
[ Mon, Mar 28th 2011 ]: Market Wire
Dr. Reddya?s Launches Levocetirizine Tablets in US
[ Mon, Mar 28th 2011 ]: Market Wire
Preclinical Data on AVEO Pharmaceuticalsa? Tivoza .. ipeline to be Presented at AACR 102nd Annual Meet
[ Mon, Mar 28th 2011 ]: Market Wire
A.P. Pharma Announces Fourth Quarter and Full Yea .. 0 Financial Results and Provides Corporate Update
Sun, March 27, 2011
[ Sun, Mar 27th 2011 ]: Market Wire
Helix BioPharma Announces $3.9 Million Private Placement
[ Sun, Mar 27th 2011 ]: Market Wire
Champions Announces Technology Collaboration Util .. Technology Platform for Oncology Drug Developmen
Fri, March 25, 2011
[ Fri, Mar 25th 2011 ]: Market Wire
Edwards Lifesciences to Be Added to the S&P 500 Index
[ Fri, Mar 25th 2011 ]: Market Wire
Neurologix Announces Year End 2010 Results
[ Fri, Mar 25th 2011 ]: Market Wire
Biotonix Announces Results for the 2010 Fourth Quarter and Fiscal Year
[ Fri, Mar 25th 2011 ]: Market Wire
ISOTECHNIKA REPORTS FULL YEAR AND FOURTH QUARTER 2010 FINANCIAL RESULTS
[ Fri, Mar 25th 2011 ]: Market Wire
PacificHealth Laboratories Board Names New Chairman
[ Fri, Mar 25th 2011 ]: Market Wire
Belo Sun Announces Closing of $51.8 Million Equit .. ring Including Exercise in Full of Over-Allotment
[ Fri, Mar 25th 2011 ]: Market Wire
HealthSpring, Inc. Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 25th 2011 ]: Market Wire
Long-Term Safety Data Demonstrated VIMOVOTM Is Ge .. hritis Patients at Risk for NSAID-Associated Gast
[ Fri, Mar 25th 2011 ]: Market Wire
Celsion Corporation Reports Year End 2010 Financial Results and Provides Business Update
[ Fri, Mar 25th 2011 ]: Market Wire
Teleflex Announces Global Distribution Agreement for POLYSITE® Implantable Infusion Ports
Thu, March 24, 2011
[ Thu, Mar 24th 2011 ]: Market Wire
Gilead fija precio de obligaciones senior no garantizadas por valor de $1.000 millones
[ Thu, Mar 24th 2011 ]: Market Wire
CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings
[ Thu, Mar 24th 2011 ]: Market Wire
Baxter International Inc. First Quarter 2011 Financial Results Conference Call
[ Thu, Mar 24th 2011 ]: Market Wire
Hi-Tech Pharmacal Receives Final Approval for Lidocaine HCl Jelly, 2%
[ Thu, Mar 24th 2011 ]: Market Wire
Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck
[ Thu, Mar 24th 2011 ]: Market Wire
Abiomed to Host PROTECT II Investor Meeting at ACC 2011
[ Thu, Mar 24th 2011 ]: Market Wire
Geron to Webcast Analyst and Investor Meeting on Companya?s Oncology Programs on March 29, 2011
[ Thu, Mar 24th 2011 ]: Market Wire
West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device
[ Thu, Mar 24th 2011 ]: Market Wire
Healthcare Acquisition Activity on the Rise as Key Patents Run Out
[ Thu, Mar 24th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Completes Patient E .. nical Trial Investigating REOLYSIN® in Combi
[ Thu, Mar 24th 2011 ]: Market Wire
Unigenea?s Oral Peptide Drug Delivery Technology .. ine Phase 3 Results from Tarsaa?s ORACAL Trial of
[ Thu, Mar 24th 2011 ]: Market Wire
Fase III klinische trial van Gileads onderzoeksge .. et aan primaire doelstelling voor eerste 48 weken
Wed, March 23, 2011
[ Wed, Mar 23rd 2011 ]: Market Wire
AdCare Health Systems Reports Record Fourth Quarter and Full Year 2010 Results
[ Wed, Mar 23rd 2011 ]: Market Wire
Affymax and Takeda to Present Additional Peginesa .. Patients at the National Kidney Foundation (NKF)
[ Wed, Mar 23rd 2011 ]: Market Wire
El ensayo clnico de Fase III del frmaco en fase d .. itegravir, supera el objetivo principal de 48 sem
[ Wed, Mar 23rd 2011 ]: Market Wire
A.M. Best Withdraws Ratings of Priority Health Ca .. nc. and Peninsula Health Care, Inc. Due to Merger
[ Wed, Mar 23rd 2011 ]: Market Wire
Mesa Uranium Files 43-101 Report, Expands the Green Energy Project
[ Wed, Mar 23rd 2011 ]: Market Wire
Allezoe (ALZM) Announces Organ Transport Systems' Medical Advisory Members
[ Wed, Mar 23rd 2011 ]: Market Wire
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
[ Wed, Mar 23rd 2011 ]: Market Wire
Prana Biotechnology Limited Raises A$6.12 Million in a Private Placement
[ Wed, Mar 23rd 2011 ]: Market Wire
POZEN Announces Licensing Deal with Cilag GmbH, A .. Johnson & Johnson, for MT 400, Migraine Treatment
[ Wed, Mar 23rd 2011 ]: Market Wire
Nordion announces Phase III clinical trial to eva .. or liver metastases in colorectal cancer patients
[ Wed, Mar 23rd 2011 ]: Market Wire
CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction
[ Wed, Mar 23rd 2011 ]: Market Wire
Announcement of the Execution of a License Agreement for Unoprostone
Tue, March 22, 2011
[ Tue, Mar 22nd 2011 ]: Market Wire
New Acetadote® Formulation Now Available in the U.S.
[ Tue, Mar 22nd 2011 ]: Market Wire
Amyris aumenta sua capacidade de produo atrav©s de acordo com a Paraso Bioenergia
[ Tue, Mar 22nd 2011 ]: Market Wire
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinic .. Academy of Allergy, Asthma and Immunology (AAAAI)
[ Tue, Mar 22nd 2011 ]: Market Wire
Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup
[ Tue, Mar 22nd 2011 ]: Market Wire
LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO
[ Tue, Mar 22nd 2011 ]: Market Wire
Radient Pharmaceuticals Receives Additional Deficiency Notice From NYSE Amex
[ Tue, Mar 22nd 2011 ]: Market Wire
POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation
[ Tue, Mar 22nd 2011 ]: Market Wire
Amyris Adds Additional Production Capacity Through Agreement With Paraso Bioenergia
[ Tue, Mar 22nd 2011 ]: Market Wire
Pro-Pharmaceuticals Expands Patent Portfolio with New Patents in the U.S. and Australia
[ Tue, Mar 22nd 2011 ]: Market Wire
Emergent BioSolutions to Present at Needham & Company Healthcare Conference
[ Tue, Mar 22nd 2011 ]: Market Wire
Schiff Nutrition International, Inc. Announces Fiscal 2011 Third Quarter Results
[ Tue, Mar 22nd 2011 ]: Market Wire
Given Imaging to Present at the 10th Annual Needham Healthcare Conference
Mon, March 21, 2011
[ Mon, Mar 21st 2011 ]: Market Wire
2010 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS
[ Mon, Mar 21st 2011 ]: Market Wire
U.S. Physical Therapy to Present at the Sidoti Fi .. nual Emerging Growth Institutional Investor Forum
[ Mon, Mar 21st 2011 ]: Market Wire
30 p.m. ET
[ Mon, Mar 21st 2011 ]: Market Wire
Anacor Pharmaceuticals Secures $30 Million Loan Facility
[ Mon, Mar 21st 2011 ]: Market Wire
RXi Pharmaceuticals Presents New Preclinical RNAi .. one Mechanism and Biology of Silencing Conference
[ Mon, Mar 21st 2011 ]: Market Wire
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA
[ Mon, Mar 21st 2011 ]: Market Wire
Amyris and U.S. Venture Announce Plans for Joint Venture in Development of Renewable Lubricants
[ Mon, Mar 21st 2011 ]: Market Wire
Biotech Sector Is a Hotbed of Takeover Speculation
[ Mon, Mar 21st 2011 ]: Market Wire
Teleflex Announces Retirement of 2004 Senior Notes
[ Mon, Mar 21st 2011 ]: Market Wire
Given Imaging Wins Patent Infringement Lawsuit in Germany
[ Mon, Mar 21st 2011 ]: Market Wire
XenoPort Reports Results from a Phase 2b Clinical .. il as Adjunctive Treatment for Patients with GERD
[ Mon, Mar 21st 2011 ]: Market Wire
Santarus and Pharming Announce RHUCIN Poster at A .. Allergy, Asthma & Immunology 2011 Annual Meeting
Sun, March 20, 2011
[ Sun, Mar 20th 2011 ]: Market Wire
Curis Announces Positive Results in Genentech Piv .. rial of GDC-0449 in Advanced Basal Cell Carcinoma
Fri, March 18, 2011
[ Fri, Mar 18th 2011 ]: Market Wire
Forest Laboratories Announces Expiration of Hart- .. o Waiting Period for Acquisition of Clinical Data
[ Fri, Mar 18th 2011 ]: Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Therag
[ Fri, Mar 18th 2011 ]: Market Wire
Allezoe (ALZM) Announces Organ Transport Systems .. paring for Clinical Trials; Will Prioritize Heart
[ Fri, Mar 18th 2011 ]: Market Wire
Comit© voor geneesmiddelen voor menselijk gebrui .. deelt positief over nieuwe anticonceptie NOMAC-E2
[ Fri, Mar 18th 2011 ]: Market Wire
CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB
[ Fri, Mar 18th 2011 ]: Market Wire
Rotech Healthcare Inc. Announces Closing of Priva .. Offering of $290 Million Senior Second Lien Notes
[ Fri, Mar 18th 2011 ]: Market Wire
Committee for Medicinal Products for Human Use (C .. Opinion for New Contraception Offering, NOMAC-E2
[ Fri, Mar 18th 2011 ]: Market Wire
Teva Receives Positive Opinion for NOMAC/E2 from the European Committee for Medicinal Products
[ Fri, Mar 18th 2011 ]: Market Wire
Affymax Announces Pricing of Public Offering of Common Stock
[ Fri, Mar 18th 2011 ]: Market Wire
Algoma Central Corporation Announces Increase to Bought Deal Financing
[ Fri, Mar 18th 2011 ]: Market Wire
Cytokinetics Announces Fundamental Research in th .. yosin Activation Published in the Journal Science
[ Fri, Mar 18th 2011 ]: Market Wire
Declarao da Covidien sobre o impacto do terremoto japons
Thu, March 17, 2011
[ Thu, Mar 17th 2011 ]: Market Wire
Covidien Statement on the Impact of the Japanese Earthquake
[ Thu, Mar 17th 2011 ]: Market Wire
HearUSA Responds to Siemens Filing
[ Thu, Mar 17th 2011 ]: Market Wire
SunCoast RHIO Joins Connect HIN - Florida Health Information Network (FLHIN)
[ Thu, Mar 17th 2011 ]: Market Wire
CPEX Pharmaceuticals Advises Stockholders to Take .. Response to Mangrove Partnersa? Revised Proposal
[ Thu, Mar 17th 2011 ]: Market Wire
Antrim Energy Inc. Announces Closing of Financing
[ Thu, Mar 17th 2011 ]: Market Wire
Radient Pharmaceuticals Hires DLA Piper to Defend Company Against Class Action Lawsuit
[ Thu, Mar 17th 2011 ]: Market Wire
Self Funding Administrators Corporation Joins American CareSource's Growing Client Portfolio
[ Thu, Mar 17th 2011 ]: Market Wire
ImmuCell Announces Sales and Marketing Collaboration With AgriLabs
[ Thu, Mar 17th 2011 ]: Market Wire
Prime Equity Research Initiates Independent Coverage On Fresh Start
[ Thu, Mar 17th 2011 ]: Market Wire
Oncolytics Biotech® Inc. Announces 2010 Year End Results
[ Thu, Mar 17th 2011 ]: Market Wire
Alnylam Responds to Tekmira Complaint
[ Thu, Mar 17th 2011 ]: Market Wire
AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011
Wed, March 16, 2011
[ Wed, Mar 16th 2011 ]: Market Wire
El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor
[ Wed, Mar 16th 2011 ]: Market Wire
Covidien elige como presidente y director ejecutivo a Jose E. Almeida
[ Wed, Mar 16th 2011 ]: Market Wire
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
[ Wed, Mar 16th 2011 ]: Market Wire
PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER
[ Wed, Mar 16th 2011 ]: Market Wire
Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo
[ Wed, Mar 16th 2011 ]: Market Wire
Covidien Elects Jose E. Almeida President and Chief Executive Officer
[ Wed, Mar 16th 2011 ]: Market Wire
Covidien CEO to Retire July 1; Successor Named
[ Wed, Mar 16th 2011 ]: Market Wire
Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt
[ Wed, Mar 16th 2011 ]: Market Wire
CEO di Covidien in pensione dal 1 luglio - nominato successore
[ Wed, Mar 16th 2011 ]: Market Wire
TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES
[ Wed, Mar 16th 2011 ]: Market Wire
Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders
[ Wed, Mar 16th 2011 ]: Market Wire
AlphaRx Provides Corporate and Development Update
Tue, March 15, 2011
[ Tue, Mar 15th 2011 ]: Market Wire
Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting
[ Tue, Mar 15th 2011 ]: Market Wire
Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011
[ Tue, Mar 15th 2011 ]: Market Wire
Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock
[ Tue, Mar 15th 2011 ]: Market Wire
Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution
[ Tue, Mar 15th 2011 ]: Market Wire
Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration
[ Tue, Mar 15th 2011 ]: Market Wire
Biomagnetics Begins Miniaturization Process for Biosensor a" Major Step Toward Commercialization
[ Tue, Mar 15th 2011 ]: Market Wire
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results
[ Tue, Mar 15th 2011 ]: Market Wire
Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women
[ Tue, Mar 15th 2011 ]: Market Wire
Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
[ Tue, Mar 15th 2011 ]: Market Wire
Merck to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 15th 2011 ]: Market Wire
Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
[ Tue, Mar 15th 2011 ]: Market Wire
Illumina Prices $800 Million Convertible Senior Notes
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ]: Market Wire
Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
[ Mon, Mar 14th 2011 ]: Market Wire
Teva to Present at the Barclays Capital 2011 Global Healthcare Conference
[ Mon, Mar 14th 2011 ]: Market Wire
Health Net, Inc. Investigating Unaccounted-for Server Drives
[ Mon, Mar 14th 2011 ]: Market Wire
Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ]: Market Wire
Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta
[ Mon, Mar 14th 2011 ]: Market Wire
HemaCare Reports Fourth Quarter and Year End Results
[ Mon, Mar 14th 2011 ]: Market Wire
Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve
[ Mon, Mar 14th 2011 ]: Market Wire
Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
[ Mon, Mar 14th 2011 ]: Market Wire
Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis
[ Mon, Mar 14th 2011 ]: Market Wire
Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ]: Market Wire
Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011
[ Mon, Mar 14th 2011 ]: Market Wire
Human Genome Sciences Appoints George Morrow to its Board of Directors
Sun, March 13, 2011
[ Sun, Mar 13th 2011 ]: Market Wire
DaVita Enhances Already Strong Governance Policies
Sat, March 12, 2011
[ Sat, Mar 12th 2011 ]: Market Wire
Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation
[ Sat, Mar 12th 2011 ]: Market Wire
Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation
[ Sat, Mar 12th 2011 ]: Market Wire
Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ]: Market Wire
The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC
[ Fri, Mar 11th 2011 ]: Market Wire
Focus and SOQUEM confirm historical REE-Cu-Fe gra .. 52% TREO, 0.15% Cu, 3.70% P2O5 and 49.9% Fe2O3 at
[ Fri, Mar 11th 2011 ]: Market Wire
Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care
[ Fri, Mar 11th 2011 ]: Market Wire
Orthofix Sports Medicine Launches Three New Products in March
[ Fri, Mar 11th 2011 ]: Market Wire
Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference
[ Fri, Mar 11th 2011 ]: Market Wire
GTSO President to Participate in Rare Earths Briefing Today at U.S. Capitol
[ Fri, Mar 11th 2011 ]: Market Wire
Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab
[ Fri, Mar 11th 2011 ]: Market Wire
CytRx Reports 2010 Financial Results
[ Fri, Mar 11th 2011 ]: Market Wire
Synta Announces Clinical Program Updates and 2010 Financial Results
[ Fri, Mar 11th 2011 ]: Market Wire
Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????
[ Fri, Mar 11th 2011 ]: Market Wire
Centric Health Reports Solid 2010 Financial Results
[ Fri, Mar 11th 2011 ]: Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
[ Thu, Mar 10th 2011 ]: Market Wire
Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci
[ Thu, Mar 10th 2011 ]: Market Wire
A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation
[ Thu, Mar 10th 2011 ]: Market Wire
Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
[ Thu, Mar 10th 2011 ]: Market Wire
Human Genome Sciences y GlaxoSmithKline anuncian .. NLYSTA® (Belimumab) para el tratamiento del lupu
[ Thu, Mar 10th 2011 ]: Market Wire
Exenatide Once Monthly Showed Positive Results in Phase 2 Study
[ Thu, Mar 10th 2011 ]: Market Wire
CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth
[ Thu, Mar 10th 2011 ]: Market Wire
Northstar Healthcare Reports 2010 Results
[ Thu, Mar 10th 2011 ]: Market Wire
Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
[ Thu, Mar 10th 2011 ]: Market Wire
Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu
[ Thu, Mar 10th 2011 ]: Market Wire
Santarus Initiates Phase I Clinical Study with SAN-300
[ Thu, Mar 10th 2011 ]: Market Wire
BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
[ Thu, Mar 10th 2011 ]: Market Wire
Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l
Wed, March 9, 2011
[ Wed, Mar 09th 2011 ]: Market Wire
Unigene to Present at the ROTH 23rd Annual OC Growth Stock Conference on March 15, 2011
[ Wed, Mar 09th 2011 ]: Market Wire
Exelixis Announces Pricing of $165.0 Million Public Offering of Common Stock

Parere positivo del Comitato per i prodotti medicinali per uso umano sul nuovo contraccettivo NOMAC-E2

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. uso-umano-sul-nuovo-contraccettivo-nomac-e2.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

UTRECHT (Paesi Bassi) e WHITEHOUSE STATION (N.J., USA)--([ BUSINESS WIRE ])--Teva Pharmaceuticals Europe BV, sussidiaria di propriet di Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), e MSD (che opera come Merck negli Stati Uniti e in Canada) (NYSE:MRK) hanno oggi annunciato che il CHMP (Committee for Medicinal Products for Human Use) dell'Agenzia europea dei medicinali (EMA, European Medicines Agency) ha emesso parere positivo sul NOMAC-E2 (nomegestrolo acetato 2,5 mg/17-estradiolo 1,5 mg), una pillola contraccettiva orale combinata (COC) monofasica sperimentale che evita le gravidanze indesiderate. NOMAC-E2 associa 2 ormoni steroidei: il nomegestrolo acetato, una progestina altamente selettiva e derivata dal progesterone, e il 17 beta estradiolo (E2), un estrogeno simile a quello naturalmente presente nel corpo femminile.

Galleria Fotografica/Multimediale Disponibile: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6652101&lang=it ]

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.